ATBB-22

N/A

Report date: 2023/10/09 10:58:16
NME

Base Information

Drug NameATBB-22
Drug Alias NameATBB-22ATBB22
ClassificationOther
Mechanisms of ActionGlucagon-like peptide 1 receptor modulators
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesApcegen Technologies Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesApcegen Technologies Pvt Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A